• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconGW Pharmaceuticals

GW Pharmaceuticals

Cannabis leaf and glass probe. Inspection of hemp.
HealthCall It Reefer Magic? FDA-Approved Cannabis-Based Drug Epidiolex Now for Sale in All 50 States
By Brittany ShootNovember 1, 2018
Sativex is a cannibanoid medecine manufactured by GW Pharmaceuticals. This mouth spray has just received approval to be launched on the French market, for limited use on patients suffering from multiple sclerosis.
HealthThis Company Made the First FDA Approved, Marijuana Based Drug. Here’s What It Wants to Do Next
By Sy MukherjeeJune 27, 2018
COLOMBIA-MARIJUANA-MEDICINE-HEALTH
HealthWhy This Kids’ Epilepsy Drug Is Almost Certainly About to Become the 1st FDA Approved Marijuana Treatment
By Sy MukherjeeApril 19, 2018
Close-Up Of Marijuana On Table
HealthThe FDA Just Torched 4 Companies for Claiming Marijuana Products Can Treat Cancer
By Sy MukherjeeNovember 2, 2017
An employee displays trimmed bud from a High CBD hemp strain at Ambary Gardens in Colorado.
HealthThe Next Big Brain Cancer Drug Could Come from Marijuana
By Sy MukherjeeFebruary 7, 2017
HealthThis Biotech May Get the First Marijuana-Based Therapy Approved in the U.S.
By Sy MukherjeeSeptember 26, 2016
HealthHere’s Why This Marijuana Drug Company’s Stock Is Soaring Today
By Sy MukherjeeJune 27, 2016
Sativex is a cannibanoid medecine manufactured by GW Pharmaceuticals.
FinanceShares of This Cannabis Drugmaker Have More Than Doubled Since Friday
By Lucinda ShenMarch 14, 2016
Droplets of oil form on the surface of a Cannabis plant in a state-owned agricultural farm in Rovigo
Health5 Companies With the Biggest Buzz in the Marijuana Industry
By Tom Huddleston Jr.April 20, 2015
1
  • 1
1
Most Popular
Magazine
The youngest-ever female CEO of a Fortune 500 company is fighting Trump's cuts to keep Medicaid strongAn image of a popular article
By Fortune EditorsMarch 24, 2026
Success
Palantir’s billionaire CEO says only two kinds of people will succeed in the AI era: trade workers — ‘or you’re neurodivergent’An image of a popular article
By Fortune EditorsMarch 24, 2026
Commentary
The Treasury just declared the U.S. insolvent. The media missed itAn image of a popular article
By Fortune EditorsMarch 23, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.